Company / Gross Margin
Pasithea Therapeutics Corp. Gross Margin History
FY2021-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
-14.7%
FY2021
5-year range
-14.7% / -14.7%
FY2021-FY2021
Trend
-
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-14.7% in FY2021.
Gross Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.26 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | - | - |
| FY2021 | -14.7% | - |
As of FY2021 · SEC 10-K · Updated Jun 28, 2026